Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vertex

Sector Wars: Tesla Stock Tumbles As Two Leaders Rise, One Gets Sold Into Strength

As Tesla, Nvidia and Microsoft struggle, CF Industries gets sold into strength and Union Pacific and Vertex try to buck the market correction.

Investors Business Daily

As Vertex Stock Looks More Bullish, This Trade Limits Risk

The ideal scenario for this Vertex stock option trade is a rise up to 260 around April 14 with stable or rising implied volatility.

Investors Business Daily

UnitedHealth, Vertex Lead Five Stocks Looking Healthy In A Weak Market

UnitedHealth and Vertex Pharmaceuticals are among five medical stocks with healthy action in a weak market.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Futures Pare Losses, Crude Oil Jumps; Market Correction Nearing New Leg Down Amid Russia's Ukraine Invasion

Futures fell while crude oil prices skyrocketed on Russia oil embargo risks. The stock market rally is nearing February lows as Russia's Ukraine invasion continues.

Investors Business Daily

Why IBD Stock Of The Day Vertex Is Outperforming Its Biotech Brethren

Vertex stock is the IBD Stock Of The Day after bounding off its key moving averages as excitement grows for its non-cystic fibrosis plans.

Investors Business Daily

Three Shrewd Moves In A Bad Market By Top Fidelity Brains

In a bad market, what's one of the top Fidelity funds up to? Growth Discovery, one of the best mutual funds anywhere, is making three savvy moves.

Investors Business Daily

This Biopharmaceutical Company Has A Better 1-Year Return Than Tesla, Apple, Starbucks, Nvidia And Microsoft

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) creates new possibilities via medicine to cure diseases and improve people's lives, and over the past year, marked gains in investors’ portfolios.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Vertex Pharmaceuticals Clocks 27% Growth In Product Revenues, Issues FY22 Guidance

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) posted

Benzinga

Vertex Pharma Nears Year-High As Bullish Outlook, Pipeline Promise Spark Shares

Vertex Pharmaceuticals issued a bullish 2022 outlook, leading VRTX stock to approach a 12-month high early Thursday.

Investors Business Daily

1 … 7 8 9 10

People

Vladimir Putin

30,728 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated

59 stories

Steris

12 stories

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.